Levels of FGF-23, C-Reactive Protein, Alkaline Phosphatase as A Risk Factor for Renal Osteodystrophy in Chronic Kidney Disease Patients Stage IV-V
##plugins.themes.bootstrap3.article.main##
The condition of CKD is closely related to the existence of systemic disorders that affect various organs, including organs that often experience effects are the kidneys and musculoskeletal. Cases of osteoporosis are often found in patients with CKD who are commonly known as having Renal Osteodystrophy, which is defined by the presence of disorders or pathological conditions in the bones associated with CKD conditions. FGF-23, CRP, ALP are markers that have been associated with the occurrence of a renal osteodystrophy. By conducting this research, it is expected to know the relationship between the three markers and the occurrence of renal osteodystrophy. This study used a case-control design with a cross-sectional method to determine the relationship between FGF-23, CRP, ALP and renal osteodystrophy. From the CKD population with or without renal osteodystrophy, the sample was selected by consecutive sampling. After that, statistical tests were carried out in the form of descriptive tests, normality tests, risk factor assessment using 2x2 cross-tabulations, and predictive analysis of proportions using logistic regression tests. FGF-23 levels > 30 pg/ml (p-value <0.001; CI = 1.4-6.7), CRP > 3 mg/L (p-value <0.001; CI = 1.3-4.8), ALP > 120 U/L (p-value <0.001; CI = 1.7-10.6) in patients with stage IV-V CKD significantly increased the risk of renal osteodystrophy. In the multivariate analysis, ALP had the most significant value compared to these three variables. Based on this study, increased serum ALP is the most influential risk factor for renal osteodystrophy, both based on bivariate and multivariate analysis.
Downloads
References
-
Kandarini Y. Gangguan Mineral Dan Tulang Pada Penyakit Ginjal Kronik (GMT-PGK). Udayana University Press. KDIGO Guidelines. International Journal of Nephrology. 2021: 1-6.
Google Scholar
1
-
Erben RG. Physiological actions of fibroblast growth factor-23. Frontiers in Endocrinology. 2018; 9.
DOI |
Google Scholar
2
-
Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, et al. C reactive protein in patients with chronic renal diseases. Renal Failure. 2001; 23(3-4): 551-62.
DOI |
Google Scholar
3
-
Zhu JG, Cheng BC, Lee WC, Li LC, Lee CH, Long G, et al. Serum alkaline phosphatase levels are not associated with increased risk of death in prevalent hemodialysis patients: 5-year experience in a single hemodialysis center. Kidney and Blood Pressure Research. 2016; 41(4): 498-506.
DOI |
Google Scholar
4
-
Ito N, Kubota T, Kitanaka S, Fujiwara I, Adachi M, Takeuchi Y, et al. Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23. Journal of Bone and Mineral Metabolism. 2021; 39(6): 1066-1075.
DOI |
Google Scholar
5
-
Berglundh S, Malmgren L, Luthman H, McGuigan F, Åkesson K. C-reactive protein, bone loss, fracture, and mortality in elderly women: a longitudinal study in the OPRA cohort. Osteoporosis International. 2015; 26(2): 727-735.
DOI |
Google Scholar
6
-
Lee S, Choe JW, Kim HK, Sung J. High-Sensitivity C-Reactive Protein and Cancer. Journal of Epidemiology. 2011; 21(3): 161-168.
DOI |
Google Scholar
7
-
Park JC, Kovesdy CP, Duong U, Streja E, Rambod M, Nissenson AR et al. Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodialysis International. 2010; 14(2): 182-192.
DOI |
Google Scholar
8
-
Sharma U, Pal D, Prasad R. Alkaline phosphatase: An overview. Indian Journal of Clinical Biochemistry. 2014.
DOI |
Google Scholar
9
-
Seyedzadeh A, Tohidi MR, Golmohamadi S, Omrani HR, Seyedzadeh MS, Amiri S, et al. Prevalence of Renal Osteodystrophy and its Related Factors among End-stage Renal Disease Patients Undergoing Hemodialysis: Report from Imam Reza Referral Hospital of Medical University of Kermanshah, Iran. Oman Medical Journal. 2022; 37(1): e335.
DOI |
Google Scholar
10
-
Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients. Journal of Bone and Mineral Research. 2011; 26(6): 1368-1376.
DOI |
Google Scholar
11
-
Fukagawa M, Kazama JJ. FGF23: Its role in renal bone disease. Pediatric Nephrology. 2006.
DOI |
Google Scholar
12
-
Van Husen M, Fischer AK, Lehnhardt A, Klaassen I, Möller K, Müller-Wiefel DE, et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney International. 2010; 78(2): 200-206.
DOI |
Google Scholar
13
-
Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, et al. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. The Journal of Clinical Endocrinology & Metabolism. 2009; 94(2): 511-5117.
DOI |
Google Scholar
14
-
Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prime Care. 2008; 35(2): 329-344.
DOI |
Google Scholar
15
-
Zhang L, Yu Q, Chen X, Zhang M, He Y, Ji Z, et al. Mineral and bone disorder biomarkers and inflammation indexes in patients with end stage renal disease. Annals Of Palliative Medicine. 2020; 9(6): 3938-3946.
Google Scholar
16
-
Eleftheriadis T, Kartsios C, Antoniadi G, Kazila P, Dimitriadou M, Sotiriadou E, et al. The impact of chronic inflammation on bone turnover in hemodialysis patients. Renal Failure. 2008; 30(4): 431-437.
DOI |
Google Scholar
17
-
Moldovan D, Moldovan I, Rusu C, Racasan S, Patiu IM, Brumboiu A, et al. Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them? International Urology and Nephrology. 2010; 43(4): 1179-1186.
DOI |
Google Scholar
18
-
Zhang L, Yu Q, Chen X, Zhang M, He Y, Ji Z, et al. Mineral and bone disorder biomarkers and inflammation indexes in patients with end stage renal disease. Annals of Palliative Medicine. 2020; 9(6): 3938-3946.
DOI |
Google Scholar
19
-
Jarava C, Armas JR, Salgueira M, Palma A. Bone alkaline phosphatase isoenzyme in renal osteodystrophy. Nephrol Dial Transplant. 1996; 11(3): 43-46.
DOI |
Google Scholar
20
-
Damera S, Raphael KL, Baird BC, Cheung AK, Greene T, Beddhu S. Serum alkaline phosphatase levels associated with elevated serum C-reactive protein in chronic kidney disease. Kidney International. 2011; 79(2): 228–233.
DOI |
Google Scholar
21
-
Kamel AA, Elhamshary AS, Abdelgwad ER, Elsayed RA. Serum fibroblast growth factor 23 as an early biomarker for detection of renal osteodystrophy and progression of chronic kidney disease in children. Benha Journal. 2022; 7(6): 109-117.
DOI |
Google Scholar
22
Most read articles by the same author(s)
-
I Gusti Lanang Ngurah Agung Artha Wiguna,
Ketut Gede Mulyadi Ridia,
I Ketut Suyasa,
Ida Bagus Gede Arimbawa,
I Gusti Ngurah Indra Wiguna,
Febyan,
Leonardus William Kuswara,
Severe-Rigid Scoliosis Treated by Two-Staged Procedures: A Case Series , European Journal of Medical and Health Sciences: Vol. 5 No. 1 (2023) -
Rizki Zainuraditya,
I Wayan Suryanto Dusak,
I Ketut Suyasa,
I Gede Eka Wiratnaya,
Differences in the Levels of Total Volatile Organic Compound (TVOC) and Formaldehyde in Cigarette Smoke and Electrocautery Produced Smoke in Orthopaedic Surgery at IGNG Ngoerah (Sanglah) Denpasar General Hospital , European Journal of Medical and Health Sciences: Vol. 4 No. 6 (2022) -
Surya Abigamika,
Putu Astawa,
IGN Wien Aryana,
Made Agus Maharjana,
I Ketut Suyasa,
Differences in Carrying Angle, Baumann’s Angle, Anterior Humeral Line and Dash Score between Children in the Age Group of Less than 5 Years and over 5 Years at 3 Months Post Open Reduction Internal Fixation Criss-Cross Wire Fracture Supracondylar Humerus Gartland Type III , European Journal of Medical and Health Sciences: Vol. 5 No. 3 (2023) -
Kadek Gede Bakta Giri,
I Ketut Suyasa,
I. G. N. Wien Aryana,
A. A. Wiradewi Lestari,
I Wayan Juli Semadi,
Administration of Recombinant Platelet Derived Growth Factor-Bb (PDGF-Bb) Intrafracture on Shaft Femur Rat Wistar Performed Osteotomy and Intramedullary Wire Improves Healing Process of Fractures, Collagen Type I And III Levels , European Journal of Medical and Health Sciences: Vol. 4 No. 5 (2022) -
I Dewa Gede Bracika Damma Prasada,
I Wayan Suryanto Dusak,
I. G. N. Wien Aryana,
I. G. L. N. A. Artha Wiguna,
I Ketut Suyasa,
VAS Scores, Pain-Free Duration, Range of Motion, and IL-6 Levels are Better in Adductor Canal Block Compared to Genicular Nerve Block in Patients with Chronic Pain of Degenerative Disease of the Knee Joint , European Journal of Medical and Health Sciences: Vol. 5 No. 2 (2023) -
Richard Afandi,
Putu Astawa,
I Gede Eka Wiratnaya,
I Ketut Suyasa,
Elysanti Dwi Martadiani,
I Made Dwijaputra Ayusta,
Made Agus Maharjana,
The Association between Achilles Tendon Elasticity and Pirani Score with The Need for Achilles Tendon Lengthening in Patients with Congenital Talipes Equinovarus Post Ponseti Serial Casting , European Journal of Medical and Health Sciences: Vol. 5 No. 2 (2023) -
Agung Kenji Arnaya,
I Ketut Suyasa,
I Gede Eka Wiratnaya,
I Wayan Juli Sumadi,
Differences in Cell Death and BMP-2 Expression in Core Biopsy Specimens of Malignant Bone Tumors Given Hydrogen Peroxide Compared to Liquid Nitrogen , European Journal of Medical and Health Sciences: Vol. 5 No. 4 (2023) -
Agung Gde Duta Maha Putra,
I Ketut Suyasa,
Made Bramantya Karna,
Decreased IL-6 Levels more than 9,46 pg/ml and TNF-α Levels more than 14,43 pg/ml as Predictors of Functional Outcome of Oxford Knee Score 6 Weeks Post Total Knee Arthroplasty in Kellgren-Lawrence Grade IV Osteoarthritis Patients , European Journal of Medical and Health Sciences: Vol. 4 No. 6 (2022) -
I Gusti Ngurah Indra Wiguna,
Ketut Gede Mulyadi Ridia,
I Gede Eka Wiratnaya,
Ketut Siki Kawiyana,
I Ketut Suyasa,
Anak Agung Gede Priyastana,
Jonathan Andryanto,
Febyan Febyan,
I Dewa Gede Indra Pratama Putra,
Proximal Femoral Cortical Thickness Index as a Predictor of Osteoporosis in Women Aged Over 65 Years Old , European Journal of Medical and Health Sciences: Vol. 6 No. 3 (2024)